drugset / Trial / NCT01195103
Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
How does Lusedra compare with current standard of care (midazolam) for minimal to moderate sedation for regional anesthesia blocks prior to orthopedic surgery?
Timeline
- Start
- 2011-02
- Primary completion
- 2011-03
- Completion
- 2011-03
Outcome
Outcome not reported
Stopped (Business): “Funding terminated by funding source.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Midazolam | Small molecule | 1 mg | — |
| Comparator | Midazolam | Small molecule | 1.5 mg | — |
| Comparator | Midazolam | Small molecule | 2 mg | — |
| Comparator | fospropofol | Small molecule | 6.5 mg/kg | Intravenous |
| Comparator | fospropofol | Small molecule | 10 mg/kg | Intravenous |
| Background | Fentanyl | Other / unclassified | 1 ug/kg | Intravenous |
Indications
No indication recorded.